Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Simona Petričević"'
Autor:
Nataša Čolaković, Simona Petričević
Publikováno v:
Halo 194. 28:76-81
Introduction: Breast cancer is the most common form of malignancy in women. It affects about one million women worldwide every year and the incidence continues to rise. As a result of the introduction of screening procedures into everyday practice, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c3f8928093c7ab619c833b80cb29958
https://doi.org/10.5937/halo28-40727
https://doi.org/10.5937/halo28-40727
Autor:
Barbara Loboda, Nebojša Ivanović, Miroslav Granić, Darko Zdravković, Nataša Čolaković, Biljana Sredić, Zlatko Skurić, Milan Gojgić, Simona Petričević, Svetlana Oprić, Dragana Bjelica
Publikováno v:
European Journal of Surgical Oncology. 49:e88-e89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d189ad6814b50c018d454b1bd9b142ab
https://doi.org/10.1016/j.ejso.2022.11.272
https://doi.org/10.1016/j.ejso.2022.11.272
Autor:
Biljana Antonijevic, Milena Anđelković, Aleksandra Buha Djordjevic, Natasa Colakovic, Svetlana Oprić, Miroslav Granic, Dragana Javorac, Zorica Bulat, Jelena Kotur-Stevuljevic, Evica Antonijević Miljaković, Simona Petričević
Publikováno v:
Environmental Research
Breast cancer is at the forefront of female malignancy and the leading cause of cancer death among women. Gender, age, hormone therapy, smoking, exposure to endocrine disruptors and family history are significant breast cancer risk factors according
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6443a8fb0920923cad6a78308dac8539
https://doi.org/10.1016/j.envres.2021.111300
https://doi.org/10.1016/j.envres.2021.111300
Autor:
Nebojsa Ivanovic, Dragana Bjelica, Barbara Loboda, Masan Bogdanovski, Natasa Colakovic, Simona Petricevic, Milan Gojgic, Ognjen Zecic, Katarina Zecic, Darko Zdravkovic
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Pathologic complete response (pCR) after neoadjuvant systemic therapy (NAST) of early breast cancer (EBC) has been recognized as a good prognostic factor in the treatment of breast cancer because of its significant correlation with long-term disease
Externí odkaz:
https://doaj.org/article/8aab4163e0b84c9590ec1f74b1545f83